Business Wire

InnovaFeed Readies for Major U.S. Expansion

Share

InnovaFeed, the leading biotech insect producer for animal and plant nutrition, announced today that it has signed a strategic partnership with food ingredient provider ADM to further expand into the sustainable pet food industry. This partnership builds on the firms’ leadership in global sustainable agriculture and brings the insect protein industry closer to mainstream adoption.

Following five years of solid growth and key partnerships with global animal feed providers, InnovaFeed’s expansion into the U.S. market comes at a time when the industry is ripe for insect protein adoption. The partnership with ADM follows recent U.S. regulation allowing the use of black soldier fly (BSF) in food for dogs, while also pioneering the commercialization of high-quality insect ingredients in this market segment in the U.S.

With its unique production model based on industrial symbiosis, InnovaFeed demonstrates the best environmental performance in the market and operates the world's largest protein production facility and co-location symbiosis model in Nesle, France. With its circular and zero waste approach, InnovaFeed’s carbon footprint is 80% lower than its competitors.

“In the face of critical environmental issues, the global agriculture industry must do its part to adapt and meet humanity’s challenges,” said Clément Ray, InnovaFeed co-founder & CEO. “At InnovaFeed, we’re revolutionizing traditional practices by creating a new natural and efficient industrial model on a large scale for sustainably sourced food. Insect protein is the next alternative protein ready to be scaled, with massive market potential.”

“Pet solutions is a strategic growth opportunity for ADM, with $100 billion in demand growing 4.5% a year,” said Jorge Martinez, president, pet solutions for ADM. “Our agreement with InnovaFeed is another exciting expansion of our abilities in this space and our focus on creation, design and development of products and solutions that meet the needs of today’s pet owners. Pet owners increasingly are demanding the same kind of sustainable, healthy products they eat themselves, and we’re proud to work with InnovaFeed to continue to enhance our ability to meet these needs.”

Insect-based ingredients provide high-quality nutritional content with a significantly lower carbon footprint and land requirement. As such, the global market for insect protein across all verticals—including plant nutrition, animal feed, pet food and human food – is expected to surpass €100 billion ($113 billion USD) over the next few years, reflecting growing demand for sustainable ingredients as well as a supportive regulatory environment.

InnovaFeed’s proprietary breakthrough technology reproduces the natural lifecycle of the Hermetia Illucens, otherwise known as the black soldier fly, returning this high-protein insect back to its rightful place at the heart of the food chain.

InnovaFeed has already made major investments in its expansion venture. After raising €200 million from renowned investors such as Temasek and Creadev, the company will begin research and development operations at the world’s largest insect-protein facility in Decatur, Illinois, later this year, building on ADM’s expertise in pet food as well as partnerships with leading academic institutions.

InnovaFeed is also targeting the U.S. in 2022 as a promising market to launch ingredient solutions for human consumption. The company will offer new ingredients extracted from Hermetia Illucens as alternatives to animal and plant-based protein, enhancing the nutritional quality and environmental footprint of health-based consumer products, such as sports and medical nutrition products, healthy snacks and meat substitutes.

InnovaFeed’s U.S. expansion is an important step in its goal to build a sustainable food system of the future. As part of its U.S. implementation, the company will extend its historical partnerships with some of the industry's largest players, such as Barentz International, Hello Nature and Cargill.

Beyond agroindustry, the company teamed up with the World Mosquito Program to develop the first industrial-level mosquito-production facilities to fight diseases like the dengue virus.

“We’ve created a pioneering agri-food sector based on insects to feed the planet in a healthy and sustainable way,” explains Clément Ray. “Our technology will not only play a key role in the global agriculture sector today and in the years to come, but continued innovation in this space will help drive solutions to other key global challenges.”

InnovaFeed was founded in 2016 with a mission to improve the health and food sources of people and animals by drawing inspiration from natural solutions, while driving agricultural decarbonization efforts. It is a founding member of the North American Coalition for Insect Agriculture and is also a partner with the Center for Environmental Sustainability through Insect Farming, a public/private research program bringing together leading industrial players and academic experts at premier U.S. ag-tech universities.

ABOUT INNOVAFEED

Headquartered in Paris, France, InnovaFeed is a global biotech company and leading insect producer for animal and plant nutrition. The company boasts more than 250 “pragmatic and idealistic” experts committed to providing healthy nutrition, tackling climate change, creating resilient ecosystems, and preserving biodiversity. Learn more at www.innovafeed.com.

ABOUT ADM

At ADM, we unlock the power of nature to provide access to nutrition worldwide. With industry-advancing innovations, a complete portfolio of ingredients and solutions to meet any taste, and a commitment to sustainability, we give customers an edge in solving the nutritional challenges of today and tomorrow. We’re a global leader in human and animal nutrition and the world’s premier agricultural origination and processing company. Our breadth, depth, insights, facilities and logistical expertise give us unparalleled capabilities to meet needs for food, beverages, health and wellness, and more. From the seed of the idea to the outcome of the solution, we enrich the quality of life the world over. Learn more at www.adm.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Caroline Sasia
Communications Director, InnovaFeed
+ 33 6 11 30 36 71
caroline.sasia@innovafeed.com

Donya Hengehold
Financial Profiles
314.276.4995
dhengehold@finprofiles.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Parse Biosciences and Codebreaker Labs Partner to Apply Whole Transcriptome Single Cell Profiling and Causal Genomics at Scale19.12.2025 14:00:00 CET | Press Release

Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced a collaboration with Codebreaker Labs to develop and validate a breakthrough platform capable of testing thousands of genetic variants in parallel and measuring their effects at single cell resolution. By combining Codebreaker’s synthetic biology platform and variant engineering capabilities with the scale and accessibility of Parse’s Evercode™ technology, the collaboration aims to generate the causal data increasingly sought by AI developers, drug discovery teams, and clinical researchers. Today’s genomic studies rely heavily on observational data, or variants that appear in large populations. But rare and private variants, often only seen in one individual or family, are nearly impossible to study this way because too few carriers of the variant exist to draw statistically meaningful conclusions. As a result, even the most advanced models trained on observational datas

Cinemo Launches Cinemo ICO ™ , Accelerating the AI-Driven Intelligent Cockpit19.12.2025 11:00:00 CET | Press Release

Cinemo, a global leader and highly innovative one-stop-shop provider for fully integrated digital media products announces today the launch of its next-generation, AI-powered cockpit solutions - Cinemo ICO™. By bringing agentic AI, Cinemo unlocks a truly intelligent cockpit - connecting vehicles, drivers, passengers, and their digital ecosystems into one seamless, personal and context-aware flow. The first product launched within the Cinemo ICO™ portfolio is Cinemo ICO™ MediaMind, enabling advanced intelligent media discovery. It combines the latest agentic AI technology with Cinemo’s core expertise of providing automotive-grade media management, helping users effortlessly discover the right content for every ride - perfectly matched to their taste, context, and environment. With Cinemo ICO™ MediaMind, the digital media experience evolves: using cutting-edge large language models and intelligent media metadata-search, it understands every request – even vague spoken commands, and turns

Cyviz Awarded Two Classified NATO Defense Contracts19.12.2025 08:00:00 CET | Press Release

Norwegian technology and platform company Cyviz AS has been awarded two classified defense contracts by major European NATO-partner nations to deliver a fully mobile, containerised Command & Control (C2) capability, strengthening Europe’s operational readiness in high-threat and expeditionary environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218625485/en/ Image from a previous military exercise where Cyviz demonstrated a mobile command center solution. The contracts cover the design, integration, and delivery of secure, deployable operations centres engineered to NATO security standards, enabling military and security forces to establish full theatre-class command capability wherever operations require. Due to the sensitive nature of the missions, contract value and customer identities remain undisclosed. From Demonstrated Readiness to Operational Deployment The awards follow growing interest among European def

S3NS Announces SecNumCloud Qualification for PREMI3NS, its Trusted Cloud Offering19.12.2025 07:00:00 CET | Press Release

S3NS, a subsidiary of Thales in partnership with Google Cloud, today announced that PREMI3NS, its "Trusted Cloud" (Cloud de confiance) offering, has received the SecNumCloud 3.2 qualification delivered by the French National Agency for the Security of Information Systems (ANSSI). Meeting SecNumCloud 3.2’s protection and resilience requirements, which are known as the most demanding ones in France and Europe, it offers immunity from non-European extraterritorial laws. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218817208/en/ ANSSI delivered the SecNumCloud 3.2 qualification for S3NS’ PREMI3NS offering, meeting all its requirements and passing all three milestones of the qualification process. With PREMI3NS, S3NS now offers businesses and public sector organizations the most extensive cloud service among the offerings that have received the SecNumCloud 3.2 qualification. PREMI3NS integrates the most advanced IaaS and Paa

Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press Release

Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye